1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CHRNB2 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA KCNN1 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA MSH6 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA SUPT20H CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA PRKX CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA ELAVL3 CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA IGSF9B CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA TAF5L CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA RIMS3 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA UNC80 CTRPv2 pan-cancer AAC 0.14 5e-05
Download CSV